(Q36009625)

11 August 2017

1 reference

title

Valpha14 NKT cell-mediated anti-tumor responses and their clinical application (English)

1 reference

11 August 2017

1

Ken-Ichiro Seino

1 reference

11 August 2017

7

Masaru Taniguchi

1 reference

11 August 2017

Shin-Ichiro Fujii

2

1 reference

11 August 2017

Michishige Harada

3

1 reference

11 August 2017

Shinichiro Motohashi

4

1 reference

11 August 2017

Toshinori Nakayama

5

1 reference

11 August 2017

Takehiko Fujisawa

6

1 reference

11 August 2017

publication date

14 January 2005

1 reference

Seminars in Immunopathology

11 August 2017

published in

1 reference

11 August 2017

volume

27

1 reference

11 August 2017

issue

1

1 reference

11 August 2017

page(s)

65-74

1 reference

https://scigraph.springernature.com/pub.10.1007/s00281-004-0194-y

11 August 2017

exact match

0 references

cites work

Analysis of human V alpha 24+ CD4+ NKT cells activated by alpha-glycosylceramide-pulsed monocyte-derived dendritic cells

1 reference

12 December 2020

TRAIL expression by activated human CD4(+)V alpha 24NKT cells induces in vitro and in vivo apoptosis of human acute myeloid leukemia cells

1 reference

12 December 2020

Tumor necrosis factor-related apoptosis-inducing ligand (TRAIL) contributes to interferon gamma-dependent natural killer cell protection from tumor metastasis

1 reference

12 December 2020

Severe and selective deficiency of interferon-gamma-producing invariant natural killer T cells in patients with myelodysplastic syndromes

1 reference

12 December 2020

A novel function of Valpha14+CD4+NKT cells: stimulation of IL-12 production by antigen-presenting cells in the innate immune system

1 reference

12 December 2020

Natural killer-like nonspecific tumor cell lysis mediated by specific ligand-activated Valpha14 NKT cells

1 reference

12 December 2020

Immunoregulatory T cells in tumor immunity

1 reference

12 December 2020

Mechanisms of the antimetastatic effect in the liver and of the hepatocyte injury induced by alpha-galactosylceramide in mice

1 reference

12 December 2020

Sequential production of interferon-gamma by NK1.1+ T cells and natural killer cells is essential for the antimetastatic effect of alpha -galactosylceramide

1 reference

12 December 2020

Antitumor cytotoxicity mediated by ligand-activated human V alpha24 NKT cells

1 reference

12 December 2020

Transforming growth factor-beta production and myeloid cells are an effector mechanism through which CD1d-restricted T cells block cytotoxic T lymphocyte-mediated tumor immunosurveillance: abrogation prevents tumor recurrence.

1 reference

12 December 2020

Preserved IFN-alpha production of circulating Valpha24 NKT cells in primary lung cancer patients

1 reference

12 December 2020

The natural killer T (NKT) cell ligand alpha-galactosylceramide demonstrates its immunopotentiating effect by inducing interleukin (IL)-12 production by dendritic cells and IL-12 receptor expression on NKT cells

1 reference

12 December 2020

A phase I study of alpha-galactosylceramide (KRN7000)-pulsed dendritic cells in patients with advanced and recurrent non-small cell lung cancer

1 reference

12 December 2020

A phase I study of the natural killer T-cell ligand alpha-galactosylceramide (KRN7000) in patients with solid tumors

1 reference

12 December 2020

Impaired proliferative response of V alpha 24 NKT cells from cancer patients against alpha-galactosylceramide

1 reference

12 December 2020

Functionally distinct subsets of CD1d-restricted natural killer T cells revealed by CD1d tetramer staining

1 reference

12 December 2020

A reversible defect in natural killer T cell function characterizes the progression of premalignant to malignant multiple myeloma

1 reference

12 December 2020

The NKT cell system: bridging innate and acquired immunity

1 reference

12 December 2020

Expansion of human Valpha24+ NKT cells by repeated stimulation with KRN7000.

1 reference

12 December 2020

CD4+ CD25+ T cells responding to serologically defined autoantigens suppress antitumor immune responses

1 reference

12 December 2020

Human CD4+ CD25+ regulatory T cells suppress NKT cell functions

1 reference

12 December 2020

Cutting edge: inhibition of experimental tumor metastasis by dendritic cells pulsed with alpha-galactosylceramide

1 reference

12 December 2020

Human NKT cells mediate antitumor cytotoxicity directly by recognizing target cell CD1d with bound ligand or indirectly by producing IL-2 to activate NK cells

1 reference

12 December 2020

CD1d-restricted and TCR-mediated activation of valpha14 NKT cells by glycosylceramides

1 reference

12 December 2020

Structure and function of natural killer cell receptors: multiple molecular solutions to self, nonself discrimination.

1 reference

12 December 2020

Editing of CD1d-bound lipid antigens by endosomal lipid transfer proteins.

1 reference

12 December 2020

CD1 recognition by mouse NK1+ T lymphocytes

1 reference

12 December 2020

Oligosaccharides of Hyaluronan activate dendritic cells via toll-like receptor 4.

1 reference

12 December 2020

Regulation of NKT cells by Ly49: analysis of primary NKT cells and generation of NKT cell line

1 reference

12 December 2020

The regulatory role of Valpha14 NKT cells in innate and acquired immune response.

1 reference

12 December 2020

Human invariant valpha24+ natural killer T cells activated by alpha-galactosylceramide (KRN7000) have cytotoxic anti-tumour activity through mechanisms distinct from T cells and natural killer cells

1 reference

12 December 2020

The unconventional lifestyle of NKT cells

1 reference

12 December 2020

The murine nonclassical class I major histocompatibility complex-like CD1.1 molecule protects target cells from lymphokine-activated killer cell cytolysis

1 reference

12 December 2020

Mechanism of CD1d-restricted natural killer T cell activation during microbial infection.

1 reference

12 December 2020

Prolonged IFN-gamma-producing NKT response induced with alpha-galactosylceramide-loaded DCs.

1 reference

12 December 2020

Potent expansion of human natural killer T cells using alpha-galactosylceramide (KRN7000)-loaded monocyte-derived dendritic cells, cultured in the presence of IL-7 and IL-15

1 reference

12 December 2020

Invariant natural killer T cells are preserved in patients with glioma and exhibit antitumor lytic activity following dendritic cell-mediated expansion

1 reference

12 December 2020

Critical contribution of IFN-γ and NK cells, but not perforin-mediated cytotoxicity, to anti-metastatic effect of α-galactosylceramide

1 reference

12 December 2020

Detection and activation of human Valpha24+ natural killer T cells using alpha-galactosyl ceramide-pulsed dendritic cells

1 reference

12 December 2020

Crucial amino acid residues of mouse CD1d for glycolipid ligand presentation to Vα14 NKT cells

1 reference

12 December 2020

Expansion of lung V alpha 14 NKT cells by administration of alpha-galactosylceramide-pulsed dendritic cells

1 reference

12 December 2020

NKT cell-mediated repression of tumor immunosurveillance by IL-13 and the IL-4R-STAT6 pathway

1 reference

12 December 2020

Therapeutic activation of Vα24+Vβ11+ NKT cells in human subjects results in highly coordinated secondary activation of acquired and innate immunity

1 reference

12 December 2020

KIR: diverse, rapidly evolving receptors of innate and adaptive immunity

1 reference

12 December 2020

Murine CD1d-restricted T cell recognition of cellular lipids

1 reference

12 December 2020

Loss of IFN-gamma production by invariant NK T cells in advanced cancer.

1 reference

12 December 2020

10.1007/S00281-004-0194-Y

Identifiers

DOI

1 reference

11 August 2017

1 reference